Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 273 - 280 of 11440 results
In With the New? Not So Fast: The UPC’s First SEP Ruling Aligns With German Precedent
May 8, 2024| Blog| Viewpoint
Hytera Sanctions Show Strength Of Antisuit Injunctions
May 7, 2024| News
Formal Publication Of CERCLA PFAS Rule Opens Door To Legal Challenges
May 7, 2024| News
Massachusetts Judges, Trial Bar Embrace Six-Person Juries
May 6, 2024| News
FDA’s Final LDT Rule Is Here, and the Changes Show the Agency Is Serious and Actually Listening to Stakeholders
May 6, 2024| Blog| Viewpoint
What’s New in Wireless - May 2024
May 6, 2024| Blog| Viewpoint
A Guide To Using The DTSA For Misappropriation Recourse
May 6, 2024| News
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.